Bortezomib and Abdominal abscess - a phase IV clinical study of FDA data

Summary:

Abdominal abscess is reported as a side effect among people who take Bortezomib (bortezomib), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Ciclosporin, and have Thrombotic thrombocytopenic purpura.

The phase IV clinical study analyzes which people have Abdominal abscess when taking Bortezomib. It is created by eHealthMe based on reports of 30,902 people who have side effects when taking Bortezomib from the FDA, and is updated regularly.

What is Bortezomib?

Bortezomib has active ingredients of bortezomib. eHealthMe is studying from 30,912 Bortezomib users. Check the latest studies of Bortezomib.

What is Abdominal abscess?

Abdominal abscess (collection of pus in abdomen) is found to be associated with 500 drugs and 1,147 conditions by eHealthMe. Check the latest studies of Abdominal abscess.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

30,902 people reported to have side effects when taking Bortezomib.
Among them, 96 people (0.31%) have Abdominal abscess.

Could Bortezomib cause Abdominal abscess?

Among these 96 people:

How long have people been on Bortezomib when they have Abdominal abscess? *

What is the gender of people who have Abdominal abscess when taking Bortezomib? *

female: 0.0 %
male: 100 %

What is the age of people who have Abdominal abscess when taking Bortezomib? *

What are other drugs people take besides Bortezomib? *

Ciclosporin: 51 people, 53.12%
N-Acetylcysteine: 28 people, 29.17%
Cyclophosphamide: 26 people, 27.08%
Cyclosporine: 24 people, 25.00%
Acetylcysteine: 23 people, 23.96%
Acitretin: 23 people, 23.96%
Methylprednisolone Sodium Succinate: 21 people, 21.88%
Methylprednisolone: 15 people, 15.62%
Pomalyst: 2 people, 2.08%
Prednisone: 2 people, 2.08%

What are other side effects people have besides Abdominal abscess? *

Empyema (collection of pus in a cavity in the body): 92 people, 95.83%
Enterococcal Infection: 81 people, 84.38%
Klebsiella Infection: 62 people, 64.58%
Drug Ineffective: 60 people, 62.50%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 54 people, 56.25%
Staphylococcal Bacteraemia (a bacterial infection of blood): 52 people, 54.17%
Sepsis (a severe blood infection that can lead to organ failure and death): 52 people, 54.17%
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain): 42 people, 43.75%
Thrombotic Thrombocytopenic Purpura (a rare blood disorder characterized by clotting in small blood vessels of the body): 40 people, 41.67%
Device Related Infection: 39 people, 40.62%

What are the existing conditions these people have? *

Thrombotic Thrombocytopenic Purpura (a rare blood disorder characterized by clotting in small blood vessels of the body): 91 people, 94.79%
Psoriasis (immune-mediated disease that affects the skin): 44 people, 45.83%
Immunodeficiency Disorders: 5 people, 5.21%
Multiple Myeloma (cancer of the plasma cells): 2 people, 2.08%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Bortezomib and have Abdominal abscess?

- Check whether Abdominal abscess is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bortezomib:

Bortezomib (30,912 reports)

Browse all side effects of Bortezomib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal abscess:

Abdominal abscess (500 drugs)

Browse all the conditions that are associated with Abdominal abscess:

Abdominal abscess (1,147 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bortezomib (the active ingredients of Bortezomib) and Bortezomib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.